Back to NVO Stock Lookup

NVO Related Analyst Ratings

May 24, 2013 07:27 AM Natixis Upgrades Novo Nordisk (NVO) to Buy

Apr 16, 2013 08:00 AM Swedbank Upgrades Novo Nordisk (NVO) to Buy

Mar 18, 2013 07:50 AM JPMorgan Downgrades Novo Nordisk (NVO) to Underweight, Losing Ground to Competition

Feb 12, 2013 08:04 AM Nomura Securities Upgrades Novo Nordisk (NVO) to Buy Post CRL Sell-Off

Jan 28, 2013 11:34 AM Goldman Sachs Adds Novo Nordisk (NVO) to Conviction Buy List, Joining Roche and Shire plc

Sep 21, 2012 08:22 AM UBS Upgrades Novo Nordisk (NVO) to Buy

Sep 12, 2012 07:41 AM Natixis Downgrades Novo Nordisk (NVO) to Neutral

Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jun 22, 2012 03:34 PM Barclays Reiterates an 'Underweight' on Novo Nordisk (NVO); Shares Trading As If Not Risk Priced In

Jun 12, 2012 05:44 PM Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck

Jun 11, 2012 05:17 PM Barclays on Global Biopharma Stocks: American Diabetes Association 2012: Highlights From GSK, LLY, SNY, NVO & JNJ

Apr 23, 2012 10:48 AM Barclays Downgrades Novo Nordisk (NVO) to Underweight

Apr 3, 2012 08:10 AM BofA/Merrill Lynch added Novo Nordisk A/S (NVO) to its Europe 1 List

Mar 22, 2012 07:29 AM Deutsche Bank Downgrades Novo Nordisk (NVO) to Sell; Solid Qtr, But Already Priced In

Nov 17, 2011 03:59 PM Disappointing Trial Results on Albiglutide Make Glaxo Bid for Human Genome Less Likely -RBC (GSK) (HGSI)

Nov 8, 2011 01:17 PM Leerink Says Terminated Alliance with Lilly Opens Doors for M&A at Amylin (AMLN)

May 16, 2011 02:05 PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine

Apr 11, 2011 07:55 AM JPMorgan Downgrades Novo Nordisk (NVO) to Neutral

Jan 25, 2011 08:25 AM Goldman Sachs Upgrades Novo Nordisk (NVO) to Buy

Jan 18, 2011 08:18 AM Novo Nordisk A/S (NVO) Added To BofA/Merrill Lynch's Europe 1 List

Jan 14, 2011 07:37 AM Deutsche Bank Downgrades Novo Nordisk (NVO) to Sell; Valuation Too Rich; 84% Price Appreciation in 2010

Jan 12, 2011 07:51 AM Macquarie Upgrades Novo Nordisk (NVO) to Neutral

Dec 10, 2010 07:37 AM Citi Upgrades Novo Nordisk (NVO) to Buy

Nov 1, 2010 09:43 AM Credit Suisse Downgrades Novo-Nordisk (NVO) to Neutral

Oct 19, 2010 07:34 AM Societe Generale Upgrades Novo Nordisk (NVO) to Hold

Mar 31, 2010 07:39 AM Deutsche Bank Initiates Coverage on Novo Nordisk (NVO) with a Hold; Premium Company, Premium Valuation

Feb 24, 2010 07:52 AM Jefferies & Co Upgrades Novo Nordisk (NVO) to Buy; Collins Stewart Places 'Sell' Rating

Jan 26, 2010 09:22 AM Canaccord Adams Said Novo Approval Is Negative for Amylin (AMLN)

Jan 15, 2010 08:31 AM Jefferies & Co Downgrades Novo Nordisk (NVO) to Hold

Nov 12, 2009 07:55 AM Barclays Starts NVO, SNY at Overweight, GSK, AZN at Equalweight, NVS at Underweight

Sep 30, 2009 09:34 AM Hapoalim Securities Initiates Coverage on Alkermes (ALKS) with a Hold; Two Uncertain Drivers

Sep 11, 2009 07:34 AM Jefferies & Co. Initiates Coverage on Novo Nordisk (NVO) with a Buy

Aug 7, 2009 07:44 AM J.P. Morgan Downgrades Novo Nordisk (NVO) to Neutral

Jul 21, 2009 08:23 AM Credit Suisse Initiates Coverage on Novo Nordisk (NVO) with an Outperform

Jul 1, 2009 08:57 AM Goldman Sachs Upgrades Novo Nordisk A/S (NVO) to Buy

Jun 26, 2009 01:58 PM Analysts Downgrade Sanofi Aventis Amid Long-Acting Insulin Concerns; Amylin Benefiting (SNY, AMLN, NVO)

May 28, 2009 10:41 AM Goldman Sachs Downgrades Novo Nordisk (NVO) to Neutral

Apr 24, 2009 09:55 AM Citi Upgrades Novo Nordisk (NVO) to Buy

Apr 6, 2009 08:21 AM SocGen Upgrades Novo Nordisk (NVO) to Hold

Apr 3, 2009 01:17 PM Roth Downgrades Alkermes (ALKS) to Hold

Mar 26, 2009 08:38 AM UBS Upgrades Novo Nordisk (NVO) to Buy

Feb 27, 2009 09:22 AM Matrix Lighthouse Rating Changes 2/27

Feb 2, 2009 08:58 AM JP Morgan Upgrades Novo-Nordisk A/S (NVO) to Overweight

Jan 14, 2009 09:06 AM Citi Downgrades Novo Nordisk (NVO) to Sell

Dec 18, 2008 07:45 AM Merrill Lynch Upgrades Novo Nordisk (NVO) to Neutral

Nov 28, 2008 09:09 AM Matrix Lighthouse Rating Changes 11/28

Aug 29, 2008 08:35 AM Bernstein Downgrades Novo Nordisk (NVO) to Underperform

Aug 29, 2008 08:01 AM Matrix USA Rating Changes 8/29

Aug 21, 2008 08:07 AM UBS Initiates Coverage on Novo Nordisk (NVO) with a Neutral

Back to NVO Stock Lookup